Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this study, we evaluate the role of diffusion kurtosis imaging (DKI) and MR spectroscopy (MRS), two advanced imaging techniques in magnetic resonance (MR) in grading and detection of microscopic infiltrating tumour in gliomas. These parameters are of utmost importance in optimal choice and planning of treatment.
Patients treated with gliomatous brain tumours are included voluntarily. They undergo one imaging session on a 3T MR scanner prior to treatment.
DKI data are quantitively analyzed in order to estimate specific parameters in normal appearing white matter, grey matter, tumor and peritumoral edema. MRS data are analyzed quantitatively and qualitatively with peak integration, ratio calculation and classification algorithms. Histological confirmation is obtained at subsequent surgery.
Information from this study can be of significant importance in avoiding brain biopsies. Furthermore, information on microscopic tumour spread can be used during neurosurgery or in radiotherapy planning. An important advantage of these advanced MR techniques is the non-invasivity and the lack of ionizing radiation, two important issues in this relatively young patient population.
| Condition |
|---|
|
Gliomas |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Diffusion Kurtosis Imaging en MR Spectroscopy in Grading and the Characterization of Tumour Infiltration in Gliomas |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
patients diagnosed with a gliomatuous brain tumor, prior to treatment
Inclusion Criteria:
- diagnosis of gliomatous brain tumour
Exclusion Criteria:
- younger than 18 years of age
- prior treatment
- history of neurological or neurosurgical treatment
Contacts and Locations| Belgium | |
| University Hospitals of Leuven | |
| Leuven, Vlaams-Brabant, Belgium, 3001 | |
| Principal Investigator: | Stefan Sunaert, MD, PhD | University Hospitals Leuven |
| Principal Investigator: | Uwe Himmelreich, PhD | Catholic University Leuven |
More Information
No publications provided
| Responsible Party: | Universitaire Ziekenhuizen Leuven |
| ClinicalTrials.gov Identifier: | NCT01225003 History of Changes |
| Other Study ID Numbers: | S52302 |
| Study First Received: | October 19, 2010 |
| Last Updated: | September 28, 2011 |
| Health Authority: | Belgium: Institutional Review Board |
Keywords provided by Universitaire Ziekenhuizen Leuven:
|
gliomas magnetic resonance diffusion kurtosis imaging MR spectroscopy grading |
Additional relevant MeSH terms:
|
Glioma Neoplasms, Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal |
Neoplasms by Histologic Type Neoplasms Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue |
ClinicalTrials.gov processed this record on May 19, 2013